Press release
Top Trends Transforming the Gastroparesis Drugs Market Landscape in 2025: Development Of Innovative Gastroparesis Treatment
Gastroparesis Drugs Market
What Will the Gastroparesis Drugs Industry Market Size Be by 2025?
The market size for drugs treating gastroparesis has significantly increased in the past few years. The progression is predicted to continue from $5.39 billion in 2024 to $5.73 billion in 2025, representing a compound annual growth rate (CAGR) of 6.3%. The historical growth in this market is due to factors such as the side effects of current therapies, advancements in gastrointestinal motility research, clinical necessity, patient advocacy efforts, and regulatory backing.
What's the Long-Term Growth Forecast for the Gastroparesis Drugs Market Size Through 2029?
In the following years, the gastric paresis medicine market is anticipated to witness significant expansion. Its market size will reach $7.2 billion in 2029, growing at a Compound Annual Growth Rate (CAGR) of 5.9%. This growth during the predicted period is primarily due to the surge in diabetes cases, an aging population, heightened awareness and diagnosis, higher healthcare spending, and public and private financing. The key trends for the forecasted period involve enhancements in gastroenterology, bettered diagnostic methods, innovative technology, research funding, and joint research initiatives.
View the full report here:
https://www.thebusinessresearchcompany.com/report/gastroparesis-drugs-global-market-report
What Are the Key Growth Drivers Fueling the Gastroparesis Drugs Market Expansion?
Gastroparesis drug market expansion is anticipated due to the growing incidence of diabetes. Characterized by elevated blood sugar levels caused by insufficient insulin production or the body's inability to use insulin effectively, diabetes is a chronic health problem. Sedentary ways of living, poor dietary practices, genetic factors, urbanization, and aging populations drive the growing incidence of diabetes, exacerbated by limited healthcare access and increasing global obesity rates. Gastroparesis medications are often recommended to diabetic patients to minimize symptoms such as nausea, vomiting, and delayed stomach emptying, which are typical diabetes-related problems impacting gastrointestinal motility. The goal of these drugs is to enhance gastric activity and improve life quality for those suffering from diabetes-related gastroparesis. For example, the Office for Health Improvement & Disparities, a government department in the UK, reported in March 2024 that between March 2022 and March 2023, the number of individuals with type 1 diabetes following all eight suggested care practices rose by 22%, whereas for type 2 diabetes, it increased by 21%. Additionally, those achieving target HbA1c levels increased to 37.9%, the highest figure ever reported by the National Diabetes Audit (NDA). Consequently, the rising incidence of diabetes is fueling the expansion of the gastroparesis drug market.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15812&type=smp
What Are the Key Trends Driving Gastroparesis Drugs Market Growth?
The key focus of leading players in the gastroparesis drugs market is the introduction of groundbreaking drugs such as Gimoti (metoclopramide) nasal spray in order to secure a strategic advantage in the market. Gimoti (metoclopramide) nasal spray, a treatment for gastroparesis symptoms in adults, aids stomach evacuation by boosting gastrointestinal movement. The medication is absorbed directly into the circulatory system through the nasal mucosa, bypassing the gastrointestinal tract. For example, Evoke Pharma Inc., a pharmaceutical firm based in the United States, reported in April 2022 that the U.S. Food and Drug Administration (FDA) had awarded its GIMOTI (metoclopramide) nasal spray new drug product exclusivity. This exclusivity grants Evoke the sole marketing rights for the next three years, starting from the initial approval date under the Hatch-Waxman Act, shielding the product from generic counterparts.
How Is the Gastroparesis Drugs Market Segmented?
The gastroparesis drugs market covered in this report is segmented -
1) By Drug Type: Over-the-counter (OTC) Drugs, Prescription Drugs
2) By Drug Class: Prokinetic Agents, Antiemetic Drugs, Proton Pump Inhibitors, Other Drug Classes
3) By Disease Type: Diabetic Gastroparesis, Post-Surgical Gastroparesis, Idiopathic Gastroparesis, Other Disease Types
4) By Route Of Administration: Oral, Injectables, Other Routes Of Administration
5) By Distribution Channel: Hospitals, Pharmacies, Clinics, E-commerce
Subsegments:
1) Over-the-counter (OTC) Drugs: Antacids, Anti-Nausea Medications, Antiemetics, Digestive Enzyme Supplements
2) Prescription Drugs: Prokinetic Agents, Antiemetic Drugs, Antibiotics, Antidepressants
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=15812&type=smp
Which Companies Are Leading the Charge in Gastroparesis Drugs Market Innovation?
Major companies operating in the gastroparesis drugs market are Pfizer Inc., AbbVie Inc., Bayer AG, Sanofi SA., AstraZeneca plc, Abbott Laboratories, GSK plc, Takeda Pharmaceutical Inc., Teva Pharmaceutical Inc., Otsuka Pharmaceutical Co. Ltd., Bausch Health Companies Inc., Eisai Co. Ltd., Evoke Pharma Inc., Cadila Pharmaceuticals, Cipla Ltd., Neurogastrx Inc., Ipca Laboratories Ltd., ANI Pharmaceuticals Inc., Salix Pharmaceuticals Inc., Vanda Pharmaceuticals Inc., Theravance Biopharma Inc., Rhythm Pharmaceuticals Inc., Processa Pharmaceuticals Inc., Aclipse Therapeutics LLC, ETX Pharma Inc.
Which Regions Are Leading the Global Gastroparesis Drugs Market in Revenue?
North America was the largest region in the gastroparesis drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastroparesis drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15812
This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Top Trends Transforming the Gastroparesis Drugs Market Landscape in 2025: Development Of Innovative Gastroparesis Treatment here
News-ID: 4134451 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Drug
Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming…
Global Advanced Drug Delivery Systems Market Size - By Product Type(Oral Drug De …
Market Overview and Report Coverage
Advanced Drug Delivery Systems (ADDS) refer to innovative technologies designed to improve the administration and efficacy of therapeutics, enhancing the way medications are delivered to targeted areas within the body. These systems aim to optimize treatment outcomes by increasing the bioavailability, reducing side effects, and facilitating controlled drug release. Employing methods such as nanoparticles, liposomes, and implantable pumps, ADDS are revolutionizing personalized medicine and expanding therapeutic…
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Pric …
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Price, and Clinical Trials Outlook 2029 Report Highlights:
* Global Antibody Drug Conjugates Market Opportunity: > 40 Billion By 2029
* Global and Regional Antibody Drug Conjugate Market Insight
* Approved Drugs Sales Insight Global and Regional, Yearly and Quarterly, 2019 -2023
* Approved Antibody Drug Conjugates - Availability, Dosage and Price Insight
* Insight On Antibody Drug Conjugates In Clinical Trials: > 550…
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions.
Alcohol abuse and drug…
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.
Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…
